Enliven Therapeutics Inc

ELVNNASDAQ · US

Holders

REDUCEDT+7
Garland J. Scott
Enliven Therapeutics Inc · NASDAQ
−13,000 sh · $606.7K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Garland J. Scott
Enliven Therapeutics Inc · NASDAQ
+13,000 sh · $201.1K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+30
Collins Helen Louise
Enliven Therapeutics Inc · NASDAQ
+5,000 sh · $12.4K
Filed 21 Sept 2026SEC Form 4view source
ACQUIREDT+30
Hohl Benjamin
Enliven Therapeutics Inc · NASDAQ
+3,982 sh · $59.1K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Collins Helen Louise
Enliven Therapeutics Inc · NASDAQ
−240 sh · $12.4K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Hohl Benjamin
Enliven Therapeutics Inc · NASDAQ
−2,194 sh · $111.3K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Collins Helen Louise
Enliven Therapeutics Inc · NASDAQ
−2,916 sh · $145.9K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Hohl Benjamin
Enliven Therapeutics Inc · NASDAQ
−3,535 sh · $176.9K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Hohl Benjamin
Enliven Therapeutics Inc · NASDAQ
−289 sh · $14.9K
Filed 21 Sept 2026SEC Form 4view source
REDUCEDT+30
Collins Helen Louise
Enliven Therapeutics Inc · NASDAQ
−1,844 sh · $93.5K
Filed 21 Sept 2026SEC Form 4view source